Suraksha Diagnostic IPO GMP, Price, Allotment, Profit Estimate 2024

Suraksha Diagnostic IPO Description – Suraksha Diagnostic is a provider of clinical testing, diagnostic solutions, and medical consultation services. The company has an established network comprising a central reference laboratory, eight satellite laboratories, and 194 customer touchpoints, including 48 diagnostic centres and 146 primarily franchised sample collection centres, spanning across West Bengal, Bihar, Assam, and Meghalaya as of 31 March 2024. The company’s central reference laboratory is accredited by the College of American Pathologists, ensuring high-quality standards.

Suraksha Diagnostic offers an extensive portfolio of over 2,300 tests. The company’s diagnostic test menu included 788 routine pathology tests such as basic biochemistry and haematology, along with 647 specialized tests, including advanced biochemistry, histopathology, and molecular pathology. The radiology offerings comprised 748 basic and intermediate tests like X-rays, ultrasonography (USG), and CT scans, alongside 104 advanced radiology tests, including MRI and specialized CT scans. The company was equipped with 24 CT machines and 13 MRI machines.

Between Fiscal Years 2022 and 2024, Suraksha Diagnostic achieved a compounded annual growth rate (CAGR) of 20.87% in revenue. As of 31 March 2024, 43 of its diagnostic centres featured 120 polyclinic chambers, hosting over 750 specialized doctors, enhancing convenience for patients. The company also employed 1,522 permanent staff as of the same date.

Promoters of Suraksha Diagnostic – Dr. Somnath Chatterjee, Ms. Ritu Mittal, and Mr. Satish Kumar Verma

Suraksha Diagnostic IPO Details

Suraksha Diagnostic IPO Dates	Coming soon
Suraksha Diagnostic Issue Price	Coming soon
Fresh issue	Nil
Offer For Sale	1,91,89,330 shares
Total IPO size	1,91,89,330 shares
Minimum bid (lot size)	Coming soon
Face Value	INR 2 per share
Retail Allocation	35%
Listing On	NSE, BSE

Suraksha Diagnostic Financial Performance

	FY 2022	FY 2023	FY 2024
Revenue	223.19	190.13	218.71
Expenses	197.76	186.94	190.03
Net income	20.82	6.07	23.13
Margin (%)	9.33	3.19	10.58

Figures in INR Crores unless specified otherwise

Suraksha Diagnostic Offer News

Suraksha Diagnostic Valuations & Margins

	FY 2022	FY 2023	FY 2024 (Pre Issue)	FY 2024 (Post-Issue)*
EPS	3.91	1.22	4.43	4.43
PE Ratio	–	–	–	–

* Calculated on the basis of annualized Profits After Tax for FY 2024

	FY 2022	FY 2023	FY 2024
RONW (%)	15.38	4.32	14.09
NAV	27.36	29.25	33.66
ROCE (%)	23.11	9.05	21.46
EBITDA (%)	29.24	24.97	33.66
Debt/Equity	0.37	0.27	0.20

*Compiled by IPO Central from Prospectus

Suraksha Diagnostic IPO GMP Today (Daily Trend)

Suraksha Diagnostic IPO Subscription – Live Updates

Coming soon

Shares allotted to anchor investors are not included in these calculations. Similarly, shares allotted to market makers, if any, are not part of these calculations.

Suraksha Diagnostic – Comparison With Listed Peers

Suraksha Diagnostic IPO Allotment Status

Suraksha Diagnostic IPO allotment status will be available on the KFin Tech website. Click on this link to get allotment status.

Suraksha Diagnostic IPO Dates & Listing Performance

IPO Opening Date	Coming soon
IPO Closing Date	Coming soon
Finalization of Basis of Allotment	Coming soon
Initiation of refunds	Coming soon
Transfer of shares to demat accounts	Coming soon
Suraksha Diagnostic IPO Listing Date	Coming soon
Opening Price on NSE	Coming soon
Closing Price on NSE	Coming soon

Angel One –
Anand Rathi –
Antique Stock Broking –
Ajcon Global –
Arihant Capital –
Axis Capital –
Ashika Research –
BP Wealth –
Capital Market –
Canara Bank Securities –
Choice Broking –
Dalal & Broacha –
Elara Capital –
Elite Wealth –
GCL Broking –
Geojit –
GEPL Capital –
Hem Securities –
Hensex Securities –
HDFC Securities –
ICICIdirect –
IDBI Capital –
Investmentz –
Indsec Securities –
Jainam Broking –
KR Choksey –
LKP Research –
Marwadi Financial –
Motilal Oswal –
Mehta Equities –
Nirmal Bang –
Reliance Securities –
Sushil Finance –
Samco Securities –
SBI Securities –
SMC Global –
SMIFS – Subscribe
Systematix Research –
Swastika Investmart –
Ventura Securities –

Suraksha Diagnostic Offer Lead Manager

NUVAMA WEALTH MANAGEMENT LIMITED
801-804, Wing A, Building No 3, Inspire BKC,
G Block, Bandra Kurla Complex, Bandra East,
Mumbai – 400 051
Phone: +91 22 4009 4400
Email: [email protected]
Website: www.nuvama.com

Suraksha Diagnostic Offer Registrar

KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com

SURAKSHA DIAGNOSTIC LIMITED
Plot No. DG-12/1, Action Area 1D, Premises No. 02-0327,
New Town, Rajarhat, Kolkata 700 156, West Bengal, India
Phone: +91 33 66059750
Email: [email protected]
Website: www.surakshanet.com

Suraksha Diagnostic IPO FAQs

How many shares in Suraksha Diagnostic IPO are reserved for HNIs and retail investors?

The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.

How to apply for Suraksha Diagnostic Public Offer?

The best way to apply for Suraksha Diagnostic public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.